chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Varicella Information has been received from a physician and a school nurse concerning an 10 year old female who on 21-JUN-1996 was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). It was also noted that the patient was vaccinated with a dose of measles virus vaccine live (Ender-Edmonston) (+) mumps virus vaccine live (Jeryl-Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) on 17-MAY-1996 and 24-FEB-2000. A school nurse reported to the physician that between 24-MAR-2005 and 09-MAY-2005 the child developed a "more severe case" case of chickenpox, noted break through with less than 50 to 250 lesions. Unspecified medical attention was sought. The outcome was recovered. A product quality complain was not involved. No additional information is expected.
Janssen COVID-19 Vaccine EUA Chills, Bodyaches, Fever (102.6), Headache, Sweating, Dizzy, Nauseated, very tired. Fever started 4 hours after vaccine and broke the following day around 2pm. I continued to be nauseated, dizzy and have a headache through Sunday March 7th and Monday ( today) I am still tired and have dizzy spells and nauseated off and on. I do feel like it is improving though. The first night was really rough.
Started with cough, tickling around injection site, headache, fever, turned into intense vomiting and diahrrea by 3:30AM on 03/05/2015. Chills, fever, nausea, diarrhea, headache and neck ache lingered and are still present.
Diarrhea; Horrible stomach problems; This spontaneous case was reported by an other caregiver and describes the occurrence of DIARRHOEA (Diarrhea) and ABDOMINAL DISCOMFORT (Horrible stomach problems) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031M20A and 025G20-2A) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 22-Feb-2021, the patient experienced DIARRHOEA (Diarrhea) and ABDOMINAL DISCOMFORT (Horrible stomach problems). At the time of the report, DIARRHOEA (Diarrhea) and ABDOMINAL DISCOMFORT (Horrible stomach problems) outcome was unknown.            Reportedly, the dentist wanted to make a canal in the tooth, it was not possible, so they pulled the tooth. The doctor put him on antibiotic and then the diarrhea started. The reporter stated that they filled the cadaver bone with plastic.  No relevant concomitant medications were reported.  Treatment information was not provided.
Altered mental status and disorientation on next morgning.  Sent to ER for evaluation and observed seizure approx 24 hours after vaccine in ER.  Empiric therapy with ceftriaxone and acyclovir initiated and CT, MRI, labwork, and lumbar puncture performed.  Hospitalized for 3 days for evaluation and observation.  Return to normal mental status within 24 hours of seizure, and no further sequelae.
About 10 days after receiving new Covid booster with both variants I got a rash on both arms .  From above elbow to hand.  Took Pepcid, Benadryl and used topical steroids.
Had some legions (looks like shingles) on back of neck (2 larger ones and 3 smaller ones), eye brow (1 small one) and head (2-3 small ones). At first I thought it was a mosquito bite, but then the  larger ones seemed to develop a scab. All were very itchy, mostly the 2 larger ones. Took a good week to go away, but still see the marks of the 5 on the back of my neck. Others are obscured by hair. I know the Shingrix vaccine is not supposed to cause an outbreak, and that is why I am reporting this so it is documented.
Contracted COVID-19; Contracted COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 43-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 22Mar2021 as dose 1, single (Lot number: EP6955), on 12Apr2021 as dose 2, single (Lot number: EP6955) and on 13Dec2021 as dose 3 (booster), single (Lot number: FF8841) at the age of 42 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Facility type vaccine was Public Health Clinic/RA facility. No other vaccine in four weeks. No covid prior vaccination. The following information was reported: VACCINATION FAILURE (medically significant) with onset 18Jun2022, outcome "recovering", COVID-19 (medically significant) with onset 18Jun2022, outcome "recovering" and all described as "Contracted COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (18Jun2022) Positive, notes: Nasal Swab. Therapeutic measures were not taken as a result of vaccination failure, covid-19.
Information has been received from a pharmacist referring to a patient of unknown age and gender. No concurrent condition or medical history was reported. On 01-MAY-2015 the patient was inadvertently vaccinated with a dose of expired ZOSTAVAX (lot#, dose and route were unknown). The expiration date was 20-MAR-2015. No concomitant therapy was reported. Additional information has been requested.
Nausea; Dizziness; vertigo like symptoms; Not able to stand; vomiting; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old male patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number: EN6201), via an unspecified route of administration in the left arm on 13Mar2021 at 13:15 (at the age of 58-year-old), at single dose for COVID-19 immunization. The patient's medical history included high blood pressure. The patient was not diagnosed with COVID-19 prior to vaccination. The patient did not have any allergies to medications, food or other products. Concomitant medications included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL); zolpidem tartrate (AMBIEN); Amlodipine; Benazepril. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced extreme nausea, vomiting, extreme fatigue, dizziness, unable to stand without help, vertigo like symptoms, on 15Mar2021 at 18:00. Events were resulted in Doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient was not tested for COVID-19. It was unknown if any treatment received for events. The clinical outcomes of reported events were not recovered. The report was reported as non-serious.  No follow-up attempts are needed. No further information is expected.
6/5/21: Throat felt weird; it didn't hurt, but felt like it does when I eat too much candy. Very slimy I guess? 6/6/21: Throat felt the same. No other symptoms at all. 6/7/21: Throat felt the same. Went to the doctor and he said to come back if it got worse so they could test for COVID. 6/8/21: Throat felt the same, but also had a headache and other symptoms that I can't currently remember. Runny nose. Went to doctor and tested positive for COVID-19. 6/9/21: Throat started feeling very, very dry. It hurt. Lost all taste for just 4 hours. Felt sick overall and had a headache and a runny nose.  6/10/21: I don't remember how I felt, but my journal says I spent all day on the couch, so probably not very well.  6/11/21: Symptoms started disappearing/I was recovering
Pt recvd 3 doses of Engerix-B v ax & did not convert;
Patient is fully vaccinate. Presented to the ED with cough and sore throat.  Patient is a 25-year-old female presenting here with covid symptoms. She started having them 6 days ago and did test positive for Covid. She's having body aches, chills, congestion, cough that is occasionally productive. BP 131/70  | Pulse 88  | Temp 98.6 °F (37 °C) (Oral)  | Resp 20  | Ht 160 cm (5' 3")  | Wt 79.4 kg (175 lb)  | SpO2 98%  | BMI 31.00 kg/m² CXR: Subtle bibasilar pulmonary opacities. These findings can be seen with atypical pneumonia such as Covid pneumonia. She has a history of asthma recommended a short course of steroids. Was given referral to Dr. for monoclonal antibody infusion. Discharged from ED. Proceed to the emergency department immediately with any new or worsening symptoms.
Wheezing for 1 week straight, I do not have asthma so my dr prescribed prednisone. That worked immediately until 3/1/21 I started again occasional wheezing . During the entire 4 weeks I have had a shortness of breath.  I am still using the albuterol inhaler as needed.
This spontaneous report as received from a health professional refers to a 4 year old patient of unknown gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 13-NOV-2015, the patient was vaccinated with an improperly stored dose of (Oka/Merck) VARIVAX lot # L024256, expiration date: 01-JUL-2017 (exact dose and route of administration were not reported). The temperature excursion of the administered dose of vaccine was 20.3 degrees Fahrenheit for 72 hours. Data logger was involved. There were no previous excursions reported. There was no adverse effect reported. This is one of several reports received from the same reporter. Additional information has been requested.
Systemic: Lymph Node Swelling-Medium, Additional Details: She said the side effect happened 24 hours after receiving her vaccine. Discussed to follow up with the pharmacist on Thursday, April 28 to update us on the condition of her lymph nodes under her armpit.
This spontaneous report was received from a health care professional refers to 5 unspecified patients of unknown demographics. On multiple unspecified dates the patients were vaccinated with improperly stored VARIVAX (Merck) (dosing regimen unspecified) (L017145, exp: 05/13/2017). No concomitant medications reported. No adverse effects reported. M-M-R II appears on the product list because stability questions were asked, no doses of improperly stored M-M-R II were administered to patient. No further information was provided. Additional information has been requested.
after first dose my menstrual period stopped for 4 months. after the 3rd shot   menstrual periods last 6 weeks then disappear for 57 days then come back for 2 weeks and so on.
PT REPORTED REDNESS, ITCHING, PAIN, AND IRRITATION AT INJECTION SITE ON ARM.
Patient called and reported that he has flu like symptoms since he received immunizations, difficult time with sleep, vision changes (blurred vision), and feels like difficult to swallow. Patient reported that he is started to feel a little better and planning to see prescriber for follow up.
Pt developed severe pain on 11/10/23 and was unable to walk until  late on 11/12/23. She continues to  limp as of 3pm on 11/13/23. Symptoms  have not resolved. continued redness  to the injection site
the inside of his arm looked like it was sun burned, and it went all the way down to his wrist; This spontaneous report was received from a 71-year-old male consumer referring to himself. The patient's pertinent concurrent conditions included prostate cancer. The patient's medical history included heart stents (vascular stent insertion). The patient had a previous allergy to intravenous dye. The patient received  influenza virus vaccine inactivated (unspecified) (reported as flu shot), his concomitant medications included cefadroxil and other unspecified medications.    On 28-SEP-2020 (reported as 10 days ago, conflicting information also reported as 29-SEP-2020), the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) injection as prophylaxis (concentration, number of administered dose, anatomical location and route of administration, lot number and expiration date were not reported).       On 28-SEP-2020 (reported as 10 days ago), the inside of the patient's arm looked like it was sun burned, and it went all the way down to his wrist (limb injury). The patient went to the doctor and prescribed him an unspecified antibiotic as treatment. The outcome of limb injury was reported as recovered/resolved.       The causality assessment between suspect therapy and the aforementioned event was not reported.
Pt was a 17 y/o male who rec'd his first covid vaccine dose on 2/4/21. Later, when he called to schedule his 2nd dose appt, it was realized that he was only 17.  2nd dose appt  will be deferred until pt is 18 years old.
tested positive for covid 19 28 days later. mild case 3 days of fever, muscle aches, lethargy, cough and sneeze, nasal congestion
Following vax pt exp t102R, shaking movements which pt said lasted for 15-20min; Taken to ER dx feb sz; Sent home had 2nd sz on 20DEC91 & sz have persisted intermittently;
day following vax pt circumferential lt leg swelling from lt groin to lt suprapatellar red warm
Patient stated that she has blood clots in her legs due to COVID vaccine; This is a solicited report from a non-Pfizer sponsored program, received from a contactable consumer, based on information received by Pfizer.  This 38-year-old female patient was involved in a patient support program. The patient (patient ID: redacted) received apixaban. The report describes a case of thrombosis (Patient stated that she has blood clots in her legs due to COVID vaccine). Co-suspect products included COVID-19 vaccine for an unknown indication. On an unknown date, the patient started apixaban (unknown route), (unspecified dose and frequency). On an unknown date, the patient experienced thrombosis (seriousness criterion medically significant). The action taken with apixaban (unknown) was unknown. At the time of the report, thrombosis outcome was unknown. The patient received apixaban for unknown indication. The patient reported that she had blood clot in her legs due to COVID vaccine. For apixaban (unknown), the reporter considered thrombosis to be not related. Further follow up was not possible, as no further information was available.  The reporter's assessment of the causal relationship of the event with the suspect product COVID-19 vaccine was not provided at the time of this report. Since no determination has been received, the case is managed based on the company causality assessment.; Sender's Comments: BMS Medical Evaluation Comment: This patient had thrombosis after receiving apixaban study therapy. Patient also got vaccinated for COVID-19. Based on the limited information available regarding the therapy details, event onset date, action taken with the suspect and outcome of the event, it cannot be ascertained with the reasonable possibility that the apixaban could have contributed to the event thrombosis.
Partially occlusive peroneal blood clot that developed the week after he received the second Pfizer COVID vaccine
Extreme fussiness and extended crying periods, temperature of 100 rectally. Began afternoon on day of vaccines and lasted 4 days.
The nurse gave the 16 year old patient a moderna vaccine. Moderna is only for 18 and older.
This case was reported by a other health professional via call center representative and described the occurrence of fatigue in a adult female patient who received SHINGRIX (batch number Y24KE, expiry date 11th October 2020) for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced fatigue, influenza-like symptoms, pain in toe, general malaise, general body pain and wrist pain. On an unknown date, the outcome of the fatigue was recovered/resolved and the outcome of the influenza-like symptoms, pain in toe, general malaise, general body pain and wrist pain were unknown. It was unknown if the reporter considered the fatigue, influenza-like symptoms, pain in toe, general malaise, general body pain and wrist pain to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient had severe fatigue, ached all over, her wrists and toes hurt, felt like flu, totally wiped out, generalized malaise. The reporter stated that the main thing was aching all over. This case has been linked with US2018GSK158114, reported by the same reporter.
Presents for cough, SOB, fever, body aches, nausea. Admit for acute COPD exacerbation, bacterial & COVID pneumonia. Tx: solumedrol, zinc, vit c, vit d, abx. Experienced "unexpected rapid recovery" & DC'd home next day.
She felt nauseated; Her heart was beating very fast; She didn't look good, she was pale, her lips were very white; She had hard time to wake up; Her blood pressure was 160 and then it went to down to 126; She tried to come back and start to talk and was able to start to walk; Lethargic; Dizzy; Allergic reaction; This is a spontaneous report from a contactable consumer. A 37-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: EW0198, Expiration date: Unknown), dose 1 via an unspecified route of administration on 10Jul2021 15:00 as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Reporter stated, she had a, she do not know this part yet, she had a allergic reaction (Jul2021), she had a Pfizer shot yesterday at 3 o'clock in the afternoon. At 4 o'clock in the morning she felt nauseated and her heart was beating very fast (11Jul2021 04:00). She wanted to wake me up, she do not know what she said, in the morning she looked at her again she did not look good, she was pale (11Jul2021). she woke her up, she was lethargic (11Jul2021), she was like you know, she did not look good and she asked her to wake up and she had hard time to wake up (11Jul2021) but she was not, she was extremely dizzy and her lips were very white (11Jul2021). So, she took her to the bathroom, she needed help. Reporter stated, she called the paramedics and the paramedics came and her blood pressure was 160 and then it went to down to 126 (11Jul2021). She tried to come back and start to talk and was able to start to walk again (11Jul2021). Reporter again stated, it was the shot the number 1 shot the 1st shot she took for yesterday. Yes, it was a Pfizer COVID vaccine shot. Reporter stated, it's not good to get like that. she do not know if it was safe for her to have the second shot. she do not think so. Reporter stated, "EW0198 and the date that it was given was yesterday, 10Jul2021. Reporter stated her heart was beating really fast that morning and she did not feel good and she got nausea she was she was worried about her heart you know going so fast. The patient underwent lab tests and procedures which included blood pressure: 160 and then it went to down to 126 on 11Jul2021, Heart was beating: very fast on 11Jul2021. The outcome of event she tried to come back and start to talk and was able to start to walk was recovered on 11Jul2021 and for other events was unknown.
Extreme shaking and chills to the point of needing assistance to walk, nausea, migraine and headache, low grade fever, numbness in fingertips, extreme muscle pain (body), sleeplessness, fatigue
Dry throat, hyperventalation.  Cap. Benadryl.  By the end of the hour patinet's symptoms improved dramatically.   BP: 143/71 Pulse: 82 o2: 99%
I was sitting normal before my class and all of a sudden my heart started racing and I got really dizzy. It lasted until I went to sleep that night. I woke up and it had subsided but I was feeling kind of groggy. I went to get checked and they took my heart rate and nothing was done about it. That was the only time I have had an adverse reaction to any of the vaccines. I checked my heart rate with my Apple watch and it went from 90 beats per minute to 189 beats in a span of a few seconds it felt like. For the rest of the day it was at the 160 beats per minute mark.
days 2 p/vax fever 99.7, day 3-4 local swelling, erythema, itching day 7;
Painful injection site, soreness in shoulder joint, soreness in left side of neck,  migraine, hurts to lift arm. Dizziness, nauseous. Tired. Sleeplessness
Patient has redness/tenderness/scab around the injection site. Has not resolved within 9 days so was concerned. Looks like it may have been skin allergy/rxn to bandage adhesive, but pt states it's at actual injection site.
Patient received Janssen COVID19 vaccine (LOT#201A21A) in his left arm at approximately 14:43 on 5/25/21. During the 15 minute observation period, he expressed "I don't feel well" and endorsed dizziness/ lightheadedness, slight tingling feeling in fingers, and nausea. Shortly thereafter at approximately 14:50, he started to slouch and appeared faint while sitting in a chair with eyes closed. He did not fall or hit any part of his body. He was easily aroused with a touch on his arm and responded to verbal questions immediately. He denied trouble breathing, chest pain, palpitations, headache, muscle weakness, vision changes, skin reactions, swelling. He was oriented x3 and not exhibiting verbal or swallowing problems. His vitals were normal- HR 80 bpm and BP 105/80 mmHg. He was offered a receptacle to vomit in if needed; however, he did not vomit. This initial reaction was consistent with potential vasovagal reaction/ near-syncope after vaccination.   Patient was encouraged and instructed to sit on the floor to prevent injury in case of fall but he refused. Staff offered him water, a fan, and opened windows while monitoring.   Later while waiting for a ride at around 15:10, he endorsed headache (first above his eyes and then toward the back of his head) and clarified this did not feel like a typical migraine that he has had before. Then at around 15:20 he endorsed vision changes in his right eye- he could not see a portion of vision out of that eye except peripheral vision and described not being able to see writing on the right side of a whiteboard in front of him in the room. Later he described a resolution of that gap in vision but then had blurry vision out of that eye. He denied any vision changes in the left eye.   Due to alarming symptoms of vision changes and onset of headache, patient was recommended to go to ER for further observation and evaluation. He was not in urgent distress and patient did not wish for EMS to be called but agreed to go to ER when his emergency contact picked him up.    Patient's emergency contact came to pick up patient at approximately 15:40 and was recommended to take him to the ER. Patient and emergency contact were amenable to this plan. He was able to stand up and walk to the car without issues.
Information has been received from a registered nurse regarding a patient of an unknown age and gender. On 14-DEC-2012 at 07:45, ZOSTAVAX lot # H016765 was exposed to -14 for an estimated total time out of range of 13.25 hours. Last temperature recorded -17. (It was also reported that on 18-DEC-2012 at 18:30 the ZOSTAVAX lot # H016765 was exposed to -14 for an estimated total time out of range of 12.75 hours). Last temperature recorded -16. On 28-NOV-2012, the patient was vaccinated with an out of temperature range dose of ZOSTAVAX (dose and route administration were not provided) (lot # H016765) (dose number was not provided). No adverse experience had been reported. This is one of 182 reports from the same source. Additional information has been requested.
Large raised welt around injection site approximately 1 1/2" in diameter. Painful and itchy. Hydrocortisone cream applied. Still visible as of 11/2/12 - 2 months later.
pt recv vax 7APR97 & 9APR97 pt exp a red, hot, hard area (14cm x 5cm) local rxn @ the inj site & a fever of 102;pt was treated w/Epi;
Pt recvd 3 doses of Engerix-B 14JAN91, 20FEB91 & it was determined that pt did not respond to vax series; 4th dose of Engerix-B was administered to pt 13SEP91; reporter indicated that pt is unavailable for specific info;
Pt developed immediate (within seconds) wheal and flare (1 1/2 wheat) and 4-5cm erythema. No other symptoms. Benadryl given.
Pt reports feeling light headed, instructed patient to lay down with feet elevated r/t vasovagel response to Covid Vaccine.  Pt reports this happening each time he receives a injection.